Previous Medicines of Tomorrow events
Medicines of Tomorrow 2024
2024 brought together experts across four therapeutic areas where innovative new classes of medicines and treatments are on the horizon for Australians: cell and gene therapies, vaccine technology, novel antimicrobial resistance therapies and digital technologies such as artificial intelligence that are impacting medicine discovery and development processes.
Cell and gene therapies are revolutionising medicine and holds great potential to transform patient outcomes. Healthcare systems and processes, including HTA, service delivery and funding approaches, must adapt to ensure that Australians will benefit from these new technologies in efficient, patient centric healthcare delivery models. The cost, data impediments and unclear reimbursement pathways for cell and gene therapies pose a significant challenge to our existing health technology assessment system.
Advanced vaccine technologies: In a new era of infectious disease, characterised by outbreaks of emerging, re-emerging and endemic pathogens, investment in preventing disease is critical to the health of people, our economy and the sustainability of our healthcare system. Key to this is ensuring that our regulatory and reimbursement processes are ready to efficiently evaluate and appropriately value innovation and new technologies to continue to attract research and investment to Australia.
Novel antimicrobial resistance (AMR) is one of the top global public health and development threats facing man kind. It is estimated bacterial AMR was responsible for 1.27 million deaths in 2019 and has contributed to 4.95 million deaths worldwide. This session will look at the challenge of AMR, potential regulatory and reimbursement reforms, and new antimicrobial therapies in development.
Digital technologies are revolutionising the global pharmaceutical industry, through the use of AI, big data analytics and machine learning in the development of biotherapeutic products, pharmaceuticals and vaccines. How these technologies are regulated, funded and provided to patients needs to be considered in the coming years.
Australia’s first Horizon Scanning Forum – December 2022
Download the Medicines of Tomorrow 2022 Report